Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated:  4/27/2010
340
mi
from 43215
Mitchellville, MD
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated: 4/27/2010
Callender Center for Clinical Research
340
mi
from 43215
Mitchellville, MD
Click here to add this to my saved trials
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Status: Enrolling
Updated:  8/5/2010
480
mi
from 43215
New York, NY
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Status: Enrolling
Updated: 8/5/2010
Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia or Progressive Keratoconus
Status: Enrolling
Updated:  9/1/2010
423
mi
from 43215
Atlanta, GA
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia or Progressive Keratoconus
Status: Enrolling
Updated: 9/1/2010
Woolfson Eye Institute
423
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
1982
mi
from 43215
Los Angeles, CA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
David Geffen School of Medicine, UCLA
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
2107
mi
from 43215
San Francisco, CA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of California, San Francisco
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
1160
mi
from 43215
Denver, CO
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
National Jewish Health
1160
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
328
mi
from 43215
Washington,
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Georgetown University School of Medicine
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
274
mi
from 43215
Chicago, IL
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Feinberg School of Medicine, Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
277
mi
from 43215
Chicago, IL
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Illinois at Chicago, College of Medicine
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
345
mi
from 43215
Baltimore, MD
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Johns Hopkins University School of Medicine
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
642
mi
from 43215
Boston, MA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Boston University School of Medicine
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
164
mi
from 43215
Ann Arbor, MI
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Michigan Medical School
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
453
mi
from 43215
New Brunswick, NJ
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
453
mi
from 43215
New Brunswick, NJ
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
524
mi
from 43215
Charleston, SC
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
995
mi
from 43215
Houston, TX
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Texas Medical School in Houston
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated:  2/18/2011
1986
mi
from 43215
Rolling Hills Estates, CA
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated: 2/18/2011
Palos Verdes Dermatology Associates
1986
mi
from 43215
Rolling Hills Estates, CA
Click here to add this to my saved trials
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated:  2/18/2011
943
mi
from 43215
Boynton Beach, FL
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated: 2/18/2011
Berlin Center
943
mi
from 43215
Boynton Beach, FL
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1659
mi
from 43215
Casa Grande, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Casa Grande Regional Medical Center
1659
mi
from 43215
Casa Grande, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1656
mi
from 43215
Chandler, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Chandler Regional
1656
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1596
mi
from 43215
Douglas, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Southeast Arizona Medical Center
1596
mi
from 43215
Douglas, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1648
mi
from 43215
Gilbert, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Mercy Gilbert Medical Center
1648
mi
from 43215
Gilbert, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1662
mi
from 43215
Glendale, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Banner Thunderbird Medical Center
1662
mi
from 43215
Glendale, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1650
mi
from 43215
Mesa, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Banner Baywood Medical Center
1650
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1530
mi
from 43215
Morenci, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Gila Health Resources
1530
mi
from 43215
Morenci, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1669
mi
from 43215
Nogales, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Holy Cross Hospital
1669
mi
from 43215
Nogales, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1658
mi
from 43215
Phoenix, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Maricopa Medical Center
1658
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1658
mi
from 43215
Phoenix, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Phoenix Children's Hospital
1658
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1658
mi
from 43215
Phoenix, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
John C. Lincoln
1658
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1556
mi
from 43215
Safford, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Mt. Graham Regional Medical Center
1556
mi
from 43215
Safford, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1580
mi
from 43215
San Carlos, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
San Carlos Indian Hospital
1580
mi
from 43215
San Carlos, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1645
mi
from 43215
Scottsdale, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Scottsdale Healthcare
1645
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1636
mi
from 43215
Tucson, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Tucson Medical Center
1636
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1639
mi
from 43215
Tucson, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
University Medical Center
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1642
mi
from 43215
Tucson, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
St. Mary's Hospital
1642
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
1539
mi
from 43215
Whiteriver, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Whiteriver IHS Hospital
1539
mi
from 43215
Whiteriver, AZ
Click here to add this to my saved trials
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Status: Enrolling
Updated:  3/15/2011
213
mi
from 43215
Burton, MI
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Status: Enrolling
Updated: 3/15/2011
Genesys East Flint Campus
213
mi
from 43215
Burton, MI
Click here to add this to my saved trials
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Status: Enrolling
Updated:  3/28/2011
317
mi
from 43215
McHenry, IL
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Status: Enrolling
Updated: 3/28/2011
Mercy Center for Corrective Eye Surgery
317
mi
from 43215
McHenry, IL
Click here to add this to my saved trials
Hydroxychloroquine Efficacy in Chronic Urticaria
Hydroxychloroquine Efficacy in Chronic Urticaria
Status: Enrolling
Updated:  4/11/2011
333
mi
from 43215
Nashville, TN
Hydroxychloroquine Efficacy in Chronic Urticaria
Hydroxychloroquine Efficacy in Chronic Urticaria
Status: Enrolling
Updated: 4/11/2011
Vanderbilt University Allergy Sinus Asthma Program
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Cooling Pillow for Atopic Dermatitis
Novel Use of a Cooling Pillow for Treatment of Severe Hand and Neck Atopic Dermatitis
Status: Enrolling
Updated:  4/29/2011
274
mi
from 43215
Chicago, IL
Cooling Pillow for Atopic Dermatitis
Novel Use of a Cooling Pillow for Treatment of Severe Hand and Neck Atopic Dermatitis
Status: Enrolling
Updated: 4/29/2011
Northwestern University Department of Dermatology
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated:  4/29/2011
274
mi
from 43215
Chicago, IL
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated: 4/29/2011
Northwestern University, Feinberg School of Medicine, Department of Dermatology
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated:  4/29/2011
274
mi
from 43215
Chicago, IL
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated: 4/29/2011
Ann & Robert H. Lurie Children's Hospital of Chicago
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Status: Enrolling
Updated:  5/25/2011
2042
mi
from 43215
Sacramento, CA
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Status: Enrolling
Updated: 5/25/2011
University of California, Davis Department of Dermatology
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated:  6/1/2011
1636
mi
from 43215
Tucson, AZ
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated: 6/1/2011
Tucson Medical Center
1636
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated:  6/1/2011
1639
mi
from 43215
Tucson, AZ
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated: 6/1/2011
University Medical Center
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
Status: Enrolling
Updated:  6/20/2011
2027
mi
from 43215
Portland, OR
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
Status: Enrolling
Updated: 6/20/2011
Oregon Health & Science University Center for Health & Healing
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms
Status: Enrolling
Updated:  6/21/2011
480
mi
from 43215
New York, NY
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms
Status: Enrolling
Updated: 6/21/2011
Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated:  7/19/2011
1163
mi
from 43215
Englewood, CO
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated: 7/19/2011
AboutSkin Dermatology and DermSurgery, PC
1163
mi
from 43215
Englewood, CO
Click here to add this to my saved trials
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated:  7/19/2011
350
mi
from 43215
Charlotte, NC
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated: 7/19/2011
Dermatology, Laser & Vein Specialists of the Carolinas PLLC
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated:  7/19/2011
337
mi
from 43215
Nashville, TN
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated: 7/19/2011
Tennessee Clinical Research Center
337
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Status: Enrolling
Updated:  8/3/2011
467
mi
from 43215
Montclair, NJ
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Status: Enrolling
Updated: 8/3/2011
Image Dermatology P.C.
467
mi
from 43215
Montclair, NJ
Click here to add this to my saved trials